250 related articles for article (PubMed ID: 19707957)
1. Stroop and emotional Stroop interference in unaffected relatives of patients with schizophrenic and bipolar disorders: distinct markers of vulnerability?
Besnier N; Richard F; Zendjidjian X; Kaladjian A; Mazzola-Pomietto P; Adida M; Azorin JM
World J Biol Psychiatry; 2009; 10(4 Pt 3):809-18. PubMed ID: 19707957
[TBL] [Abstract][Full Text] [Related]
2. Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder.
Jabben N; Arts B; van Os J; Krabbendam L
J Clin Psychiatry; 2010 Jun; 71(6):764-74. PubMed ID: 20122370
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme polymorphism in schizophrenia, bipolar disorders, and their first-degree relatives.
Kucukali CI; Aydin M; Ozkok E; Bilge E; Zengin A; Cakir U; Kara I
Psychiatr Genet; 2010 Feb; 20(1):14-9. PubMed ID: 20010451
[TBL] [Abstract][Full Text] [Related]
4. Differential responses to emotional interference in paranoid schizophrenia and bipolar mania.
Besnier N; Kaladjian A; Mazzola-Pomietto P; Adida M; Fakra E; Jeanningros R; Azorin JM
Psychopathology; 2011; 44(1):1-11. PubMed ID: 20980782
[TBL] [Abstract][Full Text] [Related]
5. Cognitive impairment and functional outcome in schizophrenia and bipolar disorder.
Green MF
J Clin Psychiatry; 2006 Oct; 67(10):e12. PubMed ID: 17107235
[TBL] [Abstract][Full Text] [Related]
6. No evidence for physical anhedonia as a candidate symptom or an endophenotype in bipolar affective disorder.
Etain B; Roy I; Henry C; Rousseva A; Schürhoff F; Leboyer M; Bellivier F
Bipolar Disord; 2007 Nov; 9(7):706-12. PubMed ID: 17988360
[TBL] [Abstract][Full Text] [Related]
7. [Neurocognitive function in clinically stable patients with schizophrenia or bipolar disorder and normal controls].
Konstantakopoulos G; Ioannidi N; Patrikelis P; Soumani A; Oulis P; Sakkas D; Papadimitriou GN; Ploumpidis D
Psychiatriki; 2011; 22(3):195-206. PubMed ID: 21971195
[TBL] [Abstract][Full Text] [Related]
8. Executive dysfunctions as potential markers of familial vulnerability to bipolar disorder and schizophrenia.
Zalla T; Joyce C; Szöke A; Schürhoff F; Pillon B; Komano O; Perez-Diaz F; Bellivier F; Alter C; Dubois B; Rouillon F; Houde O; Leboyer M
Psychiatry Res; 2004 Jan; 121(3):207-17. PubMed ID: 14675740
[TBL] [Abstract][Full Text] [Related]
9. The impact of familial risk for schizophrenia or bipolar disorder on cognitive control during episodic memory retrieval.
Christodoulou T; Messinis L; Papathanasopoulos P; Frangou S
Psychiatry Res; 2012 May; 197(3):212-6. PubMed ID: 22417935
[TBL] [Abstract][Full Text] [Related]
10. Familial and disease specific abnormalities in the neural correlates of the Stroop Task in Bipolar Disorder.
Pompei F; Jogia J; Tatarelli R; Girardi P; Rubia K; Kumari V; Frangou S
Neuroimage; 2011 Jun; 56(3):1677-84. PubMed ID: 21352930
[TBL] [Abstract][Full Text] [Related]
11. Cognitive functioning of bipolar I patients and relatives from families with or without schizophrenia or schizoaffective disorder.
Antila M; Partonen T; Kieseppä T; Suvisaari J; Eerola M; Lönnqvist J; Tuulio-Henriksson A
J Affect Disord; 2009 Jul; 116(1-2):70-9. PubMed ID: 19117610
[TBL] [Abstract][Full Text] [Related]
12. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene.
Rybakowski JK; Borkowska A; Skibinska M; Szczepankiewicz A; Kapelski P; Leszczynska-Rodziewicz A; Czerski PM; Hauser J
Psychiatry Clin Neurosci; 2006 Feb; 60(1):70-6. PubMed ID: 16472361
[TBL] [Abstract][Full Text] [Related]
13. Quality of life in bipolar type I disorder and schizophrenia in remission: clinical and neurocognitive correlates.
Brissos S; Dias VV; Carita AI; Martinez-Arán A
Psychiatry Res; 2008 Jul; 160(1):55-62. PubMed ID: 18485488
[TBL] [Abstract][Full Text] [Related]
14. Do schizophrenia and bipolar disorders share a common disease susceptibility variant at the MMP3 gene?
Kucukali CI; Aydin M; Ozkok E; Bilge E; Orhan N; Zengin A; Kara I
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):557-61. PubMed ID: 19245826
[TBL] [Abstract][Full Text] [Related]
15. Cognitive impairment and functional outcome in schizophrenia and bipolar disorder.
Green MF
J Clin Psychiatry; 2006; 67 Suppl 9():3-8; discussion 36-42. PubMed ID: 16965182
[TBL] [Abstract][Full Text] [Related]
16. Dissociable functional connectivity changes during the Stroop task relating to risk, resilience and disease expression in bipolar disorder.
Pompei F; Dima D; Rubia K; Kumari V; Frangou S
Neuroimage; 2011 Jul; 57(2):576-82. PubMed ID: 21570470
[TBL] [Abstract][Full Text] [Related]
17. Investigating the association between neurocognition and psychosis in bipolar disorder: further evidence for the overlap with schizophrenia.
Jabben N; Arts B; Krabbendam L; van Os J
Bipolar Disord; 2009 Mar; 11(2):166-77. PubMed ID: 19267699
[TBL] [Abstract][Full Text] [Related]
18. Deficits in visual sustained attention differentiate genetic liability and disease expression for schizophrenia from Bipolar Disorder.
Kumar CT; Christodoulou T; Vyas NS; Kyriakopoulos M; Corrigall R; Reichenberg A; Frangou S
Schizophr Res; 2010 Dec; 124(1-3):152-60. PubMed ID: 20674278
[TBL] [Abstract][Full Text] [Related]
19. Executive and verbal working memory dysfunction in first-degree relatives of patients with bipolar disorder.
Bora E; Vahip S; Akdeniz F; Ilerisoy H; Aldemir E; Alkan M
Psychiatry Res; 2008 Dec; 161(3):318-24. PubMed ID: 18977035
[TBL] [Abstract][Full Text] [Related]
20. [Psychosis, bipolar disorders and cognition].
Vidailhet P
Encephale; 2009 Oct; 35 Suppl 5():S164-7. PubMed ID: 19909839
[No Abstract] [Full Text] [Related]
[Next] [New Search]
